GEN Exclusives

More »

GEN News Highlights

More »
Jan 30, 2008

Study paves way for development of macular degeneration cures

  • Contact: David Harrison
    david@harrisoncommunications.net
    410-804-1728
    Foundation Fighting Blindness

    Animal model partially funded by the Foundation Fighting Blindness developed at Cleveland Clinic, published in Nature Medicine

    January 28, 2008 Owings Mills, MD -- A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.

    This is the first time that scientists have been able to create an AMD animal model that closely represents the disease in people, said Stephen Rose, Ph.D., Chief Research Officer, Foundation Fighting Blindness. Though there are some treatments for the wet form of AMD, we still dont have a cure for the condition, and millions of people are still at risk of losing their vision to both the dry and wet forms. This new model will greatly enhance the development of better treatments and potentially a cure.

    Researchers at the Cleveland Clinic Lerner College of Medicine used oxidative chemicals to sensitize the immune systems in mice and create AMD . The study is titled Oxidative damage-induced inflammation initiates age-related macular degeneration, and was published in the online edition of the scientific journal Nature Medicine on January 27.

    Once developed, therapies for the dry form, or early stage of AMD, could be implemented before vision is lost, which would be a dramatic breakthrough in the treatment of the disease, Rose said.

    ###

    For a copy of the study visit: http://www.nature.com/nm/journal/vaop/ncurrent/abs/nm1709.html

    For questions or interview requests, contact David Harrison, Foundation Fighting Blindness, 410-804-1728.

    The Foundation Fighting Blindness (www.FightBlindness.org) is the largest source of non-governmental funding for retinal degenerative disease research in the world. The urgent mission of The Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome, and the entire spectrum of retinal degenerative diseases.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?